PHARMAC is seeking feedback on a proposal to list four brands of respiratory aerosol inhalers, resulting from a provisional agreement formed between Rex Medical Ltd and PHARMAC. 

In summary, this proposal would result in the following additional brands of certain aerosol inhalers being fully funded in the Community and able to be used in DHB Hospitals:

• Floair HFA (fluticasone propionate)
• RexAir HFA (fluticasone propionate with salmeterol)
• Meterol HFA (salmeterol)
• SalAir (salbutamol)

For more details, go to: http://www.pharmac.health.nz/news/consultation-2015-02-16-rex-medical/